Danske Bank (CPSE:DANSKE): Revisiting Valuation After Launching a DKK 5 Billion Share Buyback Program
Reviewed by Simply Wall St
Danske Bank (CPSE:DANSKE) has been in focus after launching a DKK 5 billion share buyback programme running through January 2026, a move that reduces the number of shares outstanding and returns excess capital to shareholders.
See our latest analysis for Danske Bank.
The DKK 5 billion buyback comes on top of already strong price momentum, with a roughly 53% year to date share price return and a three year total shareholder return near 190%, suggesting investors see improving fundamentals rather than a one off bump.
If Danske’s rally has you rethinking your sector exposure, this could be a good moment to broaden your lens and explore fast growing stocks with high insider ownership.
Yet with Danske trading just above its consensus target but at a steep discount to intrinsic value estimates, investors face a tougher question: is there still upside left, or is the market already pricing in future growth?
Most Popular Narrative: 2.2% Overvalued
With Danske Bank last closing at DKK 311.3 against a narrative fair value near DKK 305, the story turns on how durable its current earnings power really is.
Fair value nudged higher from about DKK 299 to roughly DKK 305, reflecting a modestly more optimistic outlook on the bank's earnings power.
The net profit margin edged up from around 39.7 percent to approximately 40.2 percent, pointing to slightly better anticipated profitability and operating efficiency.
Want to see what is hiding behind that small valuation premium? The narrative quietly bakes in slower top line growth, resilient margins, and a future earnings multiple that edges above today’s mood music. Curious which specific profit and discount assumptions do the heavy lifting here? Read on to unpack how those building blocks add up to that fair value call.
Result: Fair Value of $305 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, if digital investments translate into stronger revenue growth and credit quality stays robust, earnings could surprise on the upside and challenge that cautious fair value view.
Find out about the key risks to this Danske Bank narrative.
Another Angle on Value
While the narrative fair value of around DKK 305 suggests modest overvaluation, our DCF model paints a different picture, with fair value closer to DKK 546. This implies the shares are trading at a steep discount. Which story better fits how you expect Danske to perform?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Danske Bank for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 904 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Build Your Own Danske Bank Narrative
If you would rather dig into the numbers yourself or challenge these assumptions, you can quickly build a custom view in under three minutes: Do it your way.
A great starting point for your Danske Bank research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
Looking for more investment ideas?
Do not stop at a single bank. Your next high conviction move could be hiding in fresh ideas you uncover with the Simply Wall Street Screener today.
- Target steady income while keeping an eye on quality by scanning these 12 dividend stocks with yields > 3% for companies offering compelling yields and sustainable payout profiles.
- Position yourself ahead of the next tech shift by reviewing these 25 AI penny stocks that are building real businesses around artificial intelligence, not just hype.
- Capitalize on market mispricings by sorting through these 904 undervalued stocks based on cash flows to spot businesses trading below what their cash flows suggest they are truly worth.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
The New Payments ETF Is Live on NASDAQ:
Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.
Explore how this launch could reshape portfolios
Sponsored ContentNew: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About CPSE:DANSKE
Danske Bank
Provides various banking products and services to corporate, institutional, and international clients.
Fair value with questionable track record.
Similar Companies
Market Insights
Weekly Picks
THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

The Quiet Giant That Became AI’s Power Grid
Recently Updated Narratives
Deep Value Multi Bagger Opportunity

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Unicycive Therapeutics (Nasdaq: UNCY) – Preparing for a Second Shot at Bringing a New Kidney Treatment to Market (TEST)
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
